Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
CIA-Linked Investor Helped Quantum Systems Expand in US 
Shein Shares Slide 9% in Hong Kong IPO Debut 
Street Poller Media and The Boom of the Street Interview Ad Industry 
France Targets Shein, Temu With Fast-Fashion Fees 
Toyota Global Sales Fall as China Demand Slumps 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
OpenAI Rejects Apple Trade Secret Theft Claims 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Add as a preferred source on Google
NEW YORK, March 27, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of investors who purchased Akorn, Inc. ("Akorn") (NASDAQ:AKRX) securities between March 1, 2017 and February 26, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/akorn-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) the Company’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’ acquisition of the Company; (2) the Company lacked effective internal controls over financial reporting; and (3) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
If you suffered a loss in Akorn you have until May 7, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/akorn-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
